Neurocrine to Acquire Soleno for $53.00/Share

Neurocrine Biosciences, through Sigma Merger Sub, Inc., has commenced a tender offer to purchase all outstanding shares of Soleno Therapeutics, Inc. common stock. The offer price is $53.00 per Share, payable in cash without interest, subject to reduction for applicable withholding taxes.

The filing is made on Schedule TO under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act, and it references an offer to purchase dated April 20, 2026 and a related letter of transmittal. The tender offer is for all of Soleno’s outstanding common stock, par value $0.001 per share.